Fmoc-His(Boc)-OH,
81379-52-4,
Fmoc-His(Boc)-OH.CHA,
Fmoc-L-His(Boc)-OH,
fmoc-his(1-boc)-oh,
1-[(1,1-Dimethylethoxy)carbonyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-histidine,
fmoc-his(tau-boc)-oh,
fmoc-histidine(boc)-oh,
fmoc-n-im-boc-l-histidine,
Fmoc-His(Boc)-OH?DCHA,
SCHEMBL3439705,
1-Boc-Nalpha-Fmoc-L-histidine,
CTK8F9906,
(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-[1-[(2-methylpropan-2-yl)oxycarbonyl]imidazol-4-yl]propanoic acid,
ZINC2517142,
CF-491,
MFCD00151928,
AKOS015907010,
AC-1897,
AJ-67818,
AK170150,
AS-49158,
BC215189,
BC245607,
TL8006695,
CS-0067108,
FT-0641823,
fmoc-n-im-boc-l-histidine cyclohexylammonium salt,
379F524,
N-alpha-(9-Fluorenylmethyloxycarbonyl)-Nim-(t-butyloxycarbonyl)-L-histidine,
(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-(1-(tert-butoxycarbonyl)-1H-imidazol-4-yl)propanoic acid,
FMOC-HIS -OH,
Fmoc-His(Boc)-OH CHA,
N-Fmoc-N'-Boc-L-histidine,
CID 4255658,
CID11123631,
L-Histidine, 1-[(1,1-dimethylethoxy)carbonyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-; 1-[(1,1-Dimethylethoxy)carbonyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-histidine,